Low desire · PT-141

I want to want sex again.

When everything still works physically, but the desire just isn’t there.

Private clinician evaluation for PT-141, a prescription option that takes a different approach to sexual desire than traditional performance medications. Discreet. Private. Clinician-guided.

$199 / month · $549 / 3 months

See If PT-141 Is Right for Me

Prescription required. Available only when medically appropriate. Compounded PT-141 is not FDA approved.

A woman sitting alone in warm morning light, looking out of a window, thoughtful

In short

PT-141 is another name for bremelanotide, a melanocortin receptor agonist. It activates several melanocortin receptor subtypes, including MC4 receptors found in areas of the central nervous system, which makes it pharmacologically different from medications that primarily affect blood flow. The precise mechanism by which FDA-approved bremelanotide improves hypoactive sexual desire disorder is not fully understood. Bremelanotide is the active ingredient in FDA-approved Vyleesi, which is indicated for acquired, generalized HSDD in certain premenopausal women when the low desire is not caused by a coexisting medical or psychiatric condition, relationship problem, or medication effects; it is not indicated to enhance sexual performance and is not FDA approved for male low libido or erectile dysfunction. Compounded PT-141 dispensed through Embrace is not itself FDA approved and should not be represented as equivalent to Vyleesi. It is $199 for one month or $549 for three, prescribed only after clinician evaluation. It can temporarily raise blood pressure and lower heart rate, nausea is common, and it is contraindicated in uncontrolled hypertension or known cardiovascular disease.

This isn’t really about having more sex.

It’s about missing the part of yourself that used to want it.

Maybe you still love your partner. You still find them attractive. You can still enjoy sex once you’re there. But getting there feels different.

You rarely initiate. You don’t think about sex the way you used to. Your partner notices. Then come the questions — are you still attracted to me, is something wrong, why don’t you ever want me anymore.

And maybe the hardest part is that you don’t have an answer. You want to be able to say “of course I want you.”

But privately you’re thinking:

“Why don’t I actually feel that desire anymore?”

That is the problem PT-141 is meant to start a conversation about.

An erection is not the same thing as desire

A lot of sexual-health treatment starts with mechanics. Blood flow. Erection quality. Lubrication. Performance. Those problems matter. But they are not the same as wanting sex.

You can be physically capable of having sex and still have very little interest in initiating it. That distinction is why PT-141 belongs on a completely different page from sildenafil or tadalafil.

PT-141 is another name for bremelanotide, a melanocortin receptor agonist. It activates several melanocortin receptor subtypes, including MC4 receptors found in areas of the central nervous system. The precise mechanism through which FDA-approved bremelanotide improves hypoactive sexual desire disorder is not fully understood.

That matters. We are not going to tell you that it “switches libido on.” We are not going to pretend scientists know more than they do. What makes bremelanotide different is that its pharmacology is centered on melanocortin signaling in the central nervous system rather than primarily acting as a blood-flow medication.

Editorial diagram contrasting a central nervous system signaling pathway with a peripheral blood-flow pathway

Two different questions

Solving the wrong problem is one reason people become frustrated with sexual-health treatment.

Traditional ED treatment asks: can your body respond?

The mechanism

PDE5 inhibitors such as sildenafil and tadalafil primarily affect the physiological erectile response through vascular mechanisms.

When it fits

If the issue is erection quality, your clinician may recommend an ED pathway. That is a different page and a different conversation.

A desire-focused evaluation asks: do you want sex in the first place?

The mechanism

Bremelanotide acts through melanocortin receptors in the central nervous system rather than primarily on blood flow.

When it fits

If the issue is low desire, the evaluation should look deeper — at medications, hormones, stress, pain, mental health, sleep, life stage, relationship dynamics and other medical conditions before assuming a prescription is the answer.

“This sounds exactly like me.”

PT-141 may be worth discussing if you find yourself saying things like this.

“I don’t just want more sex. I want to want it again.”

You miss spontaneous desire. You miss thinking about sex without forcing yourself to.

“My partner thinks it’s them.”

You may still love them deeply. But repeated rejection can start feeling personal to the person on the other side.

“Everything works. The desire just isn’t there.”

Physical function and sexual desire are different things.

“I’m tired of forcing myself to get in the mood.”

You don’t want sex to become another task on your schedule.

“I miss feeling like that part of me is still alive.”

Sometimes low desire feels less like a bedroom problem and more like losing part of your identity.

What Embrace does differently

We don’t start with “Buy PT-141.” We start with a harder question: why is your desire low?

That distinction matters because low sexual desire can be associated with many different factors — medication effects, hormonal changes, stress, pain, mental health, relationship dynamics, medical conditions, sleep, life stage, or a diagnosable sexual-desire disorder. A prescription should not be used to cover up a problem that needs a different solution. So your clinician can consider:

When your desire changed, and whether it was previously different
Whether low desire occurs broadly or only in certain situations
Current medications
Relevant medical history
Cardiovascular risk and blood pressure
Hormonal or life-stage factors when relevant
Pain or discomfort
Psychological and relationship factors
Whether another treatment pathway makes more sense
Whether PT-141 is clinically appropriate

Sometimes PT-141 may be appropriate. Sometimes another treatment makes more sense. Sometimes a prescription is not the answer. We think you deserve to know the difference.

Editorial illustration of a private intake form flowing into a clinician review step

What you are actually buying

Not a guaranteed sexual response. A clinician-guided decision about whether this treatment fits your situation.

Pricing

One month, or three.

The difference is the treatment window, not the medication. Prescription required, and treatment is provided only when a clinician determines it is medically appropriate.

A woman reviewing information on a tablet at a kitchen table in soft daylight

PT-141 Injection

1 month

$199

Best for someone who wants to begin with the shorter option.

A lower-commitment starting point if your clinician determines treatment is appropriate.

Private online evaluation
Clinician review
No automatic prescription

Start My Private Evaluation

PT-141 Injection

3 months

$549

Equivalent to $183/month. Save $48 versus three separate purchases.

Best for someone whose clinician recommends treatment and who prefers a longer supply.

Private online evaluation
Clinician review
Discreet fulfillment where available

Choose 3 Months and Save $48

“I’ve already tried everything.”

Maybe you have tried supplements, date nights, therapy, hormones, testosterone, lingerie, toys, scheduling sex, taking a vacation, waiting, forcing yourself to initiate, and trying not to think about it.

None of that means PT-141 will automatically work for you. But it does mean your next step probably shouldn’t be another random guess.

Start by figuring out what kind of problem you are actually dealing with.

“How do I know this isn’t another libido gimmick?”

Don’t trust the phrase “libido booster.” Ask better questions.

What medication is it? What pathway does it affect? Is the product FDA approved? Is it compounded? What does the evidence actually show? What are the risks? Who should not use it? Who is reviewing my medical history?

Those questions matter more than an Instagram testimonial. Embrace will tell you what we know. And what we don’t.

“Is PT-141 FDA approved?”

This deserves a precise answer. Bremelanotide is the active ingredient in the FDA-approved drug Vyleesi.

FDA-approved Vyleesi is specifically indicated for certain premenopausal women with acquired, generalized hypoactive sexual desire disorder when the low desire is not caused by another medical or psychiatric condition, a relationship problem, or medication or drug effects. It is not indicated to enhance sexual performance.

If the PT-141 dispensed through Embrace is compounded, that compounded medication itself is not FDA approved and has not undergone FDA premarket review for safety, effectiveness or quality. It should not be described as generic Vyleesi or as equivalent to Vyleesi.

“Can men use PT-141?”

A clinician may evaluate bremelanotide or compounded PT-141 differently depending on the patient’s circumstances and applicable prescribing rules.

However, the FDA-approved indication for Vyleesi is limited to certain premenopausal women with acquired, generalized HSDD. It is not FDA approved as a treatment for male low libido or erectile dysfunction.

Your clinician should discuss whether any proposed use is off-label or involves a compounded medication before treatment begins.

“What if my relationship is actually the problem?”

Then that matters. A prescription is not couples therapy in a syringe.

Relationship problems can affect desire. So can stress, depression, medications, hormones, pain and medical conditions. For FDA-approved Vyleesi, the labeled HSDD indication specifically excludes low desire primarily attributable to relationship problems, medical or psychiatric conditions, or medication or drug effects.

The goal is not to prescribe around the real problem. The goal is to identify it.

Frequently asked questions

What is PT-141?

PT-141 is commonly used as another name for bremelanotide, a melanocortin receptor agonist. It activates several melanocortin receptor subtypes, including MC4 receptors found in areas of the central nervous system.

What is PT-141 used for?

An FDA-approved bremelanotide product, Vyleesi, is approved for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women. Compounded PT-141 itself is not FDA approved and may be prescribed only after clinician evaluation.

Is PT-141 the same as Viagra?

No. Sildenafil and related PDE5 inhibitors primarily affect the physiological erectile response through vascular mechanisms. Bremelanotide acts through melanocortin receptors in the central nervous system. They are different medications addressing different clinical questions.

Is PT-141 a hormone?

No. Bremelanotide is a synthetic peptide and melanocortin receptor agonist.

Is PT-141 FDA approved?

The answer depends on exactly what product is being discussed. Vyleesi is an FDA-approved bremelanotide injection with a specific indication. A compounded PT-141 preparation is not itself FDA approved and has not undergone FDA premarket review for safety, effectiveness or quality. It should not be described as generic Vyleesi or as equivalent to Vyleesi.

Is this only for women?

The approved Vyleesi indication is limited to certain premenopausal women with acquired, generalized HSDD. It is not FDA approved as a treatment for male low libido or erectile dysfunction. Any other use requires an individualized clinician assessment and may be off-label. Your clinician should discuss whether any proposed use is off-label or involves a compounded medication before treatment.

Will PT-141 make me want sex?

We would not promise that, and no responsible clinician should. Response varies from person to person. FDA approval of branded bremelanotide is based on a specific clinical population and indication, and your clinical situation may differ. The purpose of the evaluation is to determine whether this treatment makes sense for you, not to promise a particular sexual response.

How quickly does it work?

Do not base your decision on internet claims about an exact onset time for compounded PT-141. Your prescription instructions should come from the clinician and dispensing pharmacy based on the formulation prescribed. If your clinician determines treatment is appropriate, follow those instructions rather than dosing information found online.

What are the side effects?

Important adverse effects and warnings associated with FDA-approved Vyleesi include nausea, flushing, headache, injection-site reactions, temporary increases in blood pressure, temporary reductions in heart rate and focal hyperpigmentation. FDA-approved Vyleesi is contraindicated in people with uncontrolled hypertension or known cardiovascular disease and is not recommended for people at high cardiovascular risk.

Can it repair my relationship?

No medication should be advertised as repairing a relationship. Low desire may be one factor affecting intimacy, but relationship difficulties often have several causes. For FDA-approved Vyleesi, the labeled HSDD indication specifically excludes low desire primarily attributable to relationship problems, medical or psychiatric conditions, or medication or drug effects.

Do I need a prescription, and will everyone qualify?

Yes, a prescription is required. And no, not everyone qualifies. You cannot buy it without completing the evaluation, and completing the evaluation does not guarantee a prescription.

How much does Embrace PT-141 cost?

Embrace PT-141 is currently offered at $199 for one month or $549 for three months, subject to clinician approval.

A different question

If what you miss is closeness rather than desire.

PT-141 is primarily a desire conversation — “I want to want sex again.” Oxytocin is primarily an intimacy and connection conversation — “I miss feeling close.” Those two experiences can overlap, but they are not identical.

If nothing dramatic happened and the closeness just changed, that may be a different evaluation. Be warned that the evidence there is considerably weaker, and the oxytocin page says so plainly.

Read about oxytocin

Compounded intranasal oxytocin is not FDA approved for low libido or pair bonding.

The real risk may be continuing to ignore it.

Low desire is easy to postpone. You tell yourself you’re tired. Busy. Stressed. You’ll deal with it next month. Then months pass. You initiate less. Your partner asks less. Eventually neither of you talks about it.

That can feel easier. Until “we haven’t been intimate lately” quietly becomes: when did we become roommates?

A prescription cannot guarantee that won’t happen. But pretending the change isn’t there won’t tell you why it happened either. You do not have to promise anyone more sex. You do not have to force yourself to perform. You can simply start with one question: what changed?

Start My Private Evaluation

Find out whether PT-141 or another treatment pathway may be appropriate for you. Completing an evaluation does not guarantee a prescription.

Clinical and legal disclosure

Prescription required. Compounded medications are prepared for individual patients pursuant to a valid prescription when permitted by applicable law. Compounded drugs are not FDA approved. FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed.

Bremelanotide is the active ingredient in FDA-approved Vyleesi. FDA-approved Vyleesi is indicated for acquired, generalized hypoactive sexual desire disorder in premenopausal women when low desire is not caused by a coexisting medical or psychiatric condition, relationship problem, or medication or drug effects. It is not indicated to enhance sexual performance.

The compounded PT-141 product offered through Embrace is not Vyleesi, is not FDA approved and should not be considered an FDA-approved generic equivalent.

Treatment is not appropriate for everyone. The clinician will consider your symptoms, medical history, medications, cardiovascular status, blood pressure and other factors. Do not use this page as a substitute for professional medical advice. Seek emergency medical attention for a medical emergency. Individual results vary.